Larimar Therapeutics (LRMR) Enterprise Value: 2013-2020
Historic Enterprise Value for Larimar Therapeutics (LRMR) over the last 7 years, with Dec 2020 value amounting to $328.8 million.
- Larimar Therapeutics' Enterprise Value rose 12874.34% to $328.8 million in Q4 2020 from the same period last year, while for Dec 2020 it was $328.8 million, marking a year-over-year increase of 217.04%. This contributed to the annual value of $246.9 million for FY2024, which is 23.61% up from last year.
- As of Q4 2020, Larimar Therapeutics' Enterprise Value stood at $328.8 million, which was up 151.66% from $130.6 million recorded in Q3 2020.
- Over the past 5 years, Larimar Therapeutics' Enterprise Value peaked at $328.8 million during Q4 2020, and registered a low of -$73.6 million during Q2 2020.
- In the last 3 years, Larimar Therapeutics' Enterprise Value had a median value of $31.0 million in 2018 and averaged $77.8 million.
- Examining YoY changes over the last 5 years, Larimar Therapeutics' Enterprise Value showed a top increase of 12,874.34% in 2020 and a maximum decrease of 1,346.12% in 2020.
- Over the past 5 years, Larimar Therapeutics' Enterprise Value (Quarterly) stood at -$42.3 million in 2016, then skyrocketed by 159.01% to $24.9 million in 2017, then soared by 158.30% to $64.4 million in 2018, then plummeted by 103.99% to -$2.6 million in 2019, then skyrocketed by 12,874.34% to $328.8 million in 2020.
- Its Enterprise Value was $328.8 million in Q4 2020, compared to $130.6 million in Q3 2020 and -$73.6 million in Q2 2020.